Email this article 
New Insights into Oral Cancer—Risk Factors and Prevention: A Review of Literature
Abstract
Keywords
Full Text:
PDFReferences
Irani S. Metastasis to head and neck area: A 16‑year retrospective
study. Am J Otolaryngol 2011;32:24‑7.
Irani S. Herbal medicine and oral health: A review. J Int Oral
Health 2016;8:989‑94.
Nakashima T, Tomita H, Hirata A, Ishida K, Hisamatsu K,
Hatano Y, et al. Promotion of cell proliferation by the
proto‑oncogene DEK enhances oral squamous cell carcinogenesis
through field cancerization. Cancer Med 2017;6:2424‑39.
Irani S. Distant metastasis from oral cancer: A review and
molecular biologic aspects. J Int Soc Prev Community Dent
;6:265‑71.
Sathiasekar AC, Mathew DG, Jaish Lal MS, Arul Prakash AA,
Goma Kumar KU. Oral field cancerization and its clinical
implications in the management in potentially malignant
disorders. J Pharm Bioallied Sci 2017;9(Suppl 1):S23‑5.
Irani S. miRNAs signature in head and neck squamous cell
carcinoma metastasis: A literature review. J Dent (Shiraz, Iran)
;17:71‑83.
Irani S. Pre‑cancerous lesions in the oral and maxillofacial
region: A literature review with special focus on etiopathogenesis.
Iran J Pathol 2016;11:303‑22.
Ram H, Sarkar J, Kumar H, Konwar R, Bhatt MLB,
Mohammad S. Oral cancer: Risk factors and molecular
pathogenesis. J Maxillofac Oral Surg 2011;10:132‑7.
Alnuaimi AD, Wiesenfeld D, O’Brien‑Simpson NM,
Reynolds EC, McCullough MJ. Oral Candida colonization in
oral cancer patients and its relationship with traditional risk
factors of oral cancer: A matched case‑control study. Oral Oncol
;51:139‑45.
Sarode GS, Sarode SC, Patil A, Anand R, Patil SG, Rao RS,
et al. Inflammation and oral cancer: An update review on
targeted therapies. J Contemp Dent Pract 2015;16:595‑602.
Jewett A, Head C, Cacalano NA. Emerging mechanisms
of immunosuppression in oral cancers. J Dent Res
;85:1061‑73.
Rock LD, Rosin MP, Zhang L, Chan B, Shariati B, Laronde DM.
Characterization of epithelial oral dysplasia in non‑smokers: First
steps towards precision medicine. Oral Oncol 2018;78:119‑25.
Khan Z, Dreger S, Shah SMH, Pohlabeln H, Khan S, Ullah Z,
et al. Oral cancer via the bargain bin: The risk of oral cancer
associated with a smokeless tobacco product (Naswar). PloS one
;12:e0180445.
Jensen K, Afroze S, Munshi MK, Guerrier M, Glaser SS.
Mechanisms for nicotine in the development and progression of
gastrointestinal cancers. Transl Gastroint Cancer 2012;1:81‑7.
Sheikh MN, Hanif S, Zia M, Qayyum Z. Effects of nicotine on
an in vitro reconstituted model oral mucosa in terms of cytokine
production. J Ayub Med Coll Abbottabad 2011;23:80‑4.
Xue J, Yang S, Seng S. Mechanisms of cancer induction by
tobacco‑specific NNK and NNN. Cancers 2014;6:1138‑56.
Khan Z, Bisen PS. Oncoapoptotic signaling and deregulated
target genes in cancers: Special reference to oral cancer. Biochim
Biophys Acta 2013;1836:123‑45.
Feng L, Wang L. Effects of alcohol on the morphological
and structural changes in oral mucosa. Pak J Med Sci
;29:1046‑9.
Hayes RB, Ahn J, Fan X, Peters BA, Ma Y, Yang L, et al.
Association of oral microbiome with risk for incident head and
neck squamous cell cancer. JAMA Oncol 2018;4:358‑65.
Neville B, Damm DD, Allen C, Chi A. Oral and Maxillofacial
Pathology. 4th ed. Canada: Saunders Elsevier; 2016.
Shigeishi H, Sugiyama M. Risk factors for oral human
papillomavirus infection in healthy individuals: A systematic
review and meta‑analysis. J Clin Med Res 2016;8:721‑9.
Elrefaey S, Massaro M, Chiocca S, Chiesa F, Ansarin M. HPV
in oropharyngeal cancer: The basics to know in clinical practice.
Acta Otorhinolaryngol Ital 2014;34:299‑309.
Yete S, D’Souza W, Saranath D. High‑risk human
papillomavirus in oral cancer: Clinical implications. Oncology
;94:133‑41.
Taberna M, Mena M, Pavon MA, Alemany L, Gillison ML,
Mesia R. Human papillomavirus‑related oropharyngeal cancer.
Ann Oncol 2017;28:2386‑98.
Han JJ, Beltran TH, Song JW, Klaric J, Choi YS. Prevalence
of genital human papillomavirus infection and human
papillomavirus vaccination rates among US adult men: National
health and nutrition examination survey (NHANES) 2013‑2014.
JAMA Oncol 2017;3:810‑6.
Jiang S, Dong Y. Human papillomavirus and oral squamous
cell carcinoma: A review of HPV‑positive oral squamous cell
carcinoma and possible strategies for future. Curr Probl Cancer
;41:323‑7.
Buitrago‑Pérez Á, Garaulet G, Vázquez‑Carballo A, Paramio JM,
García‑Escudero R. Molecular signature of HPV‑induced
carcinogenesis: pRb, p53 and gene expression profiling. Curr
Genomics 2009;10:26‑34.
Dalla Torre D, Burtscher D, Solder E, Rasse M, Puelacher W.
The correlation between the quality of oral hygiene and oral
HPV infection in adults: A prospective cross‑sectional study.
Clin Oral Investig 2019;23:179-85.
Bui TC, Markham CM, Ross MW, Mullen PD. Examining the
association between oral health and oral HPV infection. Cancer
Prev Res (Phila) 2013;6:917-24.
Sonawane K, Suk R, Chiao EY, Chhatwal J, Qiu P, Wilkin T,
et al. Oral human papillomavirus infection: Differences in
prevalence between sexes and concordance with genital human
papillomavirus infection, NHANES 2011 to 2014. Ann Intern
Med 2017;167:714‑24.
Wang CC, Palefsky JM. Human papillomavirus‑related
oropharyngeal cancer in the HIV‑infected population. Oral Dis
;22(Suppl 1):98‑106.
Vargas‑Ferreira F, Nedel F, Etges A, Gomes AP, Furuse C,
Tarquinio SB. Etiologic factors associated with oral squamous
cell carcinoma in non‑smokers and non‑alcoholic drinkers:
A brief approach. Braz Dent J 2012;23:586‑90.
Syrjanen S. Human papillomavirus (HPV) in head and neck
cancer. J Clin Virol 2005;32(Suppl 1):S59‑66.
Chocolatewala NM, Chaturvedi P. Role of human papilloma
virus in the oral carcinogenesis: An Indian perspective. J Cancer
Res Ther 2009;5:71‑7.
Candotto V, Lauritano D, Nardone M, Baggi L, Arcuri C,
Gatto R, et al. HPV infection in the oral cavity: Epidemiology,
clinical manifestations and relationship with oral cancer. Oral
Implantol (Rome) 2017;10:209‑20.
Kalavrezos N, Scully C. Mouth cancer for clinicians part 13:
Life after mouth cancer treatment. Dent Update 2016;43:672‑4,
‑8, 681‑2, 684‑6.
Nowosielska‑Grygiel J, Owczarek K, Bielinska M, Waclawek M,
Olszewski J. Analysis of risk factors for oral cavity and
oropharynx cancer in the authors’ own material. Otolaryngol Pol
;71:23‑8.
Shivappa N, Hebert JR, Rosato V, Garavello W, Serraino D,
La Vecchia C. Inflammatory potential of diet and risk of oral and
pharyngeal cancer in a large case‑control study from Italy. Int J
Cancer 2017;141:471‑9.
Gattazzo F, Urciuolo A, Bonaldo P. Extracellular matrix:
A dynamic microenvironment for stem cell niche. Biochim
Biophys Acta 2014;1840:2506‑19.
Jablonska‑Trypuc A, Matejczyk M, Rosochacki S. Matrix
metalloproteinases (MMPs), the main extracellular matrix (ECM)
enzymes in collagen degradation, as a target for anticancer drugs.
J Enzyme Inhib Med Chem 2016;31(Suppl 1):177‑83.
Webb AH, Gao BT, Goldsmith ZK, Irvine AS, Saleh N, Lee RP,
et al. Inhibition of MMP‑2 and MMP‑9 decreases cellular
migration, and angiogenesis in in vitro models of retinoblastoma.
BMC Cancer 2017;17:434.
Markwell SM, Weed SA. Tumor and stromal‑based contributions
to head and neck squamous cell carcinoma invasion. Cancers
;7:382‑406.
Pietruszewska W, Bojanowska‑Pozniak K, Kobos J. Matrix
metalloproteinases MMP1, MMP2, MMP9 and their tissue
inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: An
immunohistochemical study. Otolaryngol Pol 2016;70:32‑43.
Mohammad S, Ram H, Gupta PN, Husain N, Bhatt M.
Overexpression of COX‑2 in oral squamous cell carcinoma
patients undergoing chemoradiotherapy. Nat J Maxillofac Surg
;2:17‑21.
McCormick DL, Phillips JM, Horn TL, Johnson WD, Steele VE,
Lubet RA. Overexpression of COX‑2 in rat oral cancers and
prevention of oral carcinogenesis in rats by selective and
non‑selective COX inhibitors. Cancer Prev Res (Philadelphia, Pa)
;3:73‑81.
St Laurent J, Luckett R, Feldman S. HPV vaccination and the
effects on rates of HPV‑related cancers. Curr Probl Cancer
;42:493‑506.
Fernandes Q, Merhi M, Raza A, Inchakalody VP,
Abdelouahab N, Zar Gul AR, et al. Role of epstein‑barr virus in
the pathogenesis of head and neck cancers and its potential as an
immunotherapeutic target. Front Oncol 2018;8:257.
Moore MS, Bocour A, Tran OC, Qiao B, Schymura MJ,
Laraque F, et al. Effect of hepatocellular carcinoma on
mortality among individuals with Hepatitis B or Hepatitis C
infection in New York City, 2001‑2012. Open Forum Infect Dis
;5:ofy144.
Vinagre R, Vinagre IDF, Vilar ESA, Fecury AA, Martins LC.
Helicobacter pylori infection and immune profile of patients
with different gastroduodenal diseases. Arq Gastroenterol
;55:122‑7.
Inaba H, Sugita H, Kuboniwa M, Iwai S, Hamada M, Noda T,
et al. Porphyromonas gingivalis promotes invasion of oral
squamous cell carcinoma through induction of proMMP9 and its
activation. Cell Microbiol 2014;16:131‑45.
Woo BH, Kim DJ, Choi JI, Kim SJ, Park BS, Song JM, et al.
Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic
potential. Oncotarget 2017;8:46981‑92.
Irani S. Oral Health and Related Factors: An Update. J Int Oral
Health 2016;8:140‑4.
Irani S. Orofacial bacterial infectious diseases: An update. J Int
Soc Prev Community Dent 2017;7(Suppl 2):S61‑7.
Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S.
Presence of porphyromonas gingivalis in gingival squamous cell
carcinoma. Int J Oral Sci 2011;3:209‑15.
Petersen PE, Bourgeois D, Ogawa H, Estupinan‑Day S,
Ndiaye C. The global burden of oral diseases and risks to oral
health. Bull World Health Organ 2005;83:661‑9.
Irani S, Monsef Esfahani A, Bidari Zerehpoush F. Detection of
helicobacter pylori in oral lesions. J Dent Res Dent Clin Dent
Prospects 2013;7:230‑7.
Irani S, Monsef Esfahani A, Sabeti S, Bidari Zerehpoush F.
Detection of helicobacter pylori in oral lichen planus and oral
lichenoid reaction. Avicenna J Dent Res 2014;6:e23213.
Monsef Esfahani A, Irani S, Sabeti S, Bidari Zerehpoush F.
The possible role of helicobacter pylori in the development of
Sjogren’s syndrome and chronic sialadenitis. Avicenna J Dent
Res 2015;7:e23212.
Ali J, Sabiha B, Jan HU, Haider SA, Khan AA, Ali SS. Genetic
etiology of oral cancer. Oral Oncol 2017;70:23‑8.
Kim KM, Kim YM, Shim YS, Kim KH, Chang HS, Choi JO,
et al. Epidemiologic survey of head and neck cancers in Korea.
J Korean Med Sci 2003;18:80‑7.
Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer:
Etiology and risk factors: A review. J Cancer Res Ther
;12:458‑63.
Shah A, Malik A, Garg A, Mair M, Nair S, Chaturvedi P.
Oral sex and human papilloma virus‑related head and neck
squamous cell cancer: A review of the literature. Postgrad Med J
;93:704‑9.
Irani S, Dehghan A. The expression and functional significance
of vascular endothelial‑cadherin, CD44, and vimentin in oral
squamous cell carcinoma. J Int Soc Prev Community Dent
;8:110‑7.
Irani S, Dehghan A. Expression of vascular endothelial‑cadherin
in mucoepidermoid carcinoma: Role in cancer development.
J Int Soc Prev Community Dent 2017;7:301‑7.
Irani S, Jafari B. Expression of vimentin and CD44 in
mucoepidermoid carcinoma: A role in tumor growth. Indian J
Dent Res 2018;29:333‑40.
Irani S, Salajegheh A, Smith RA, Lam AK. A review of the
profile of endothelin axis in cancer and its management. Crit Rev
Oncol Hematol 2014;89:314‑21.
Wang TY, Peng CY, Lee SS, Chou MY, Yu CC, Chang YC.
Acquisition cancer stemness, mesenchymal transdifferentiation,
and chemoresistance properties by chronic exposure of oral
epithelial cells to arecoline. Oncotarget 2016;7:84072‑81.
Slaughter DP, Southwick HW, Smejkal W. Field cancerization
in oral stratified squamous epithelium; clinical implications of
multicentric origin. Cancer 1953;6:963‑8.
Irani S, Monsef Esfahani A, Ghorbani A. Dysplastic change rate
in cases of oral lichen planus: A retrospective study of 112 cases
in an Iranian population. J Oral Maxillofac Pathol 2016;20:395‑9.
Irani S. Squamous cell carcinoma arising in oral lichen planus.
DJH 2010;1:1‑6.
Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S.
Molecular markers in oral epithelial dysplasia: Review. J Oral
Pathol Med 2009;38:737‑52.
Braakhuis BJ, Leemans CR, Brakenhoff RH. A genetic
progression model of oral cancer: Current evidence and clinical
implications. J Oral Pathol Med 2004;33:317‑22.
van Houten VM, Tabor MP, van den Brekel MW, Kummer JA,
Denkers F, Dijkstra J, et al. Mutated p53 as a molecular
marker for the diagnosis of head and neck cancer. J Pathol
;198:476‑86.
Mohan M, Jagannathan N. Oral field cancerization: An update on
current concepts. Oncol Rev 2014;8:244.
Lydiatt WM, Anderson PE, Bazzana T, Casale M, Hughes CJ,
Huvos AG, et al. Molecular support for field cancerization in the
head and neck. Cancer 1998;82:1376‑80.
Aghazadeh Z, Pouralibaba F, Yari Khosroushahi A. The
prophylactic effect of Acetobacter syzygii probiotic species
against squamous cell carcinoma. J Dent Res Dent Clin Dent
Prospects 2017;11:208‑14.
Hatakka K, Ahola AJ, Yli‑Knuuttila H, Richardson M, Poussa T,
Meurman JH, et al. Probiotics reduce the prevalence of oral
candida in the elderly‑‑a randomized controlled trial. J Dent Res
;86:125‑30.
Verhoeven V, Renard N, Makar A, Van Royen P, Bogers JP,
Lardon F, et al. Probiotics enhance the clearance of human
papillomavirus‑related cervical lesions: A prospective controlled
pilot study. Eur J Cancer Prev 2013;22:46‑51.
Xie A, Liu J. Chemoprevention of oral cancer in leukoplakia
patients: A systematic review and meta‑analysis. J Pak Med
Assoc 2017;67:1415‑9.
Surh YJ. Cancer chemoprevention with dietary phytochemicals.
Nat Rev Cancer 2003;3:768‑80.
Surh YJ, Chun KS. Cancer chemopreventive effects of curcumin.
Adv Exp Med Biol 2007;595:149‑72.
Crooker K, Aliani R, Ananth M, Arnold L, Anant S, Thomas SM.
A review of promising natural chemopreventive agents for
head and neck cancer. Cancer Prev Res (Philadelphia, Pa)
;11:441‑50.
Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin:
A review of anti‑cancer properties and therapeutic activity in
head and neck squamous cell carcinoma. Mol Cancer 2011;10:12.
Maroof H, Irani S, Ariana A, Vider J, Gopalan V, Lam AK.
Interactions of vascular endothelial growth factor and p53 with
miR‑195 in thyroid carcinoma: Possible therapeutic targets in
aggressive thyroid cancers. Curr Cancer Drug Targets 2018. doi:
2174/1568009618666180628154727.
Mahran RI, Hagras MM, Sun D, Brenner DE. Bringing curcumin
to the clinic in cancer prevention: A review of strategies to
enhance bioavailability and efficacy. AAPS J 2017;19:54‑81.
Ramshankar V, Krishnamurthy A. Chemoprevention of oral
cancer: Green tea experience. J Nat Sci Biol Med 2014;5:3‑7.
Cádiz‑Gurrea M, Borrás‑Linares I, Lozano‑Sánchez J, Joven J,
Fernández‑Arroyo S, Segura‑Carretero A. Cocoa and grape seed
byproducts as a Source of Antioxidant and Anti‑Inflammatory
Proanthocyanidins. Int J Mol Sci 2017;18. doi: 10.3390/
ijms18020376.
Li YM, Peng J, Li LZ. Coffee consumption associated with
reduced risk of oral cancer: A meta‑analysis. Oral Surg Oral Med
Oral Pathol Oral Radiol 2016;121:381‑9.e1.
Alicandro G, Tavani A, La Vecchia C. Coffee and cancer risk:
A summary overview. Eur J Cancer Prev 2017;26:424‑32.
Zhang Y, Wang X, Cui D. Association between coffee
consumption and the risk of oral cancer: A meta‑analysis of
observational studies. Int J Clin Exp Med 2015;8:11657‑65.
Wang W, Yang Y, Zhang W, Wu W. Association of tea
consumption and the risk of oral cancer: A meta‑analysis. Oral
Oncol 2014;50:276‑81.
Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R,
et al. 13‑cis‑retinoic acid in the treatment of oral leukoplakia.
N Engl J Med 1986;315:1501‑5.
Gorsky M, Epstein JB. The effect of retinoids on premalignant
oral lesions: Focus on topical therapy. Cancer 2002;95:1258‑64.
Majumdar D, Jung KH, Zhang H, Nannapaneni S, Wang X,
Amin A, et al. Luteolin nanoparticle in chemoprevention‑in vitro
and in vivo anticancer activity. Cancer Prev Res (Philadelphia, Pa)
;7:65‑73.
Sharma P. Pomegranate for prevention and treatment of cancer:
An update. Molecules 2017;22. doi: 10.3390/molecules22010177.
Liang P, Henning SM, Schokrpur S, Wu L, Doan N, Said J,
et al. Effect of dietary omega‑3 fatty acids on tumor‑associated
macrophages and prostate cancer progression. Prostate
;76:1293‑302.
Ye Y, Scheff NN, Bernabe D, Salvo E, Ono K, Liu C, et al.
Anti‑cancer and analgesic effects of resolvin D2 in oral
squamous cell carcinoma. Neuropharmacology 2018;139:182‑93.
Bauman JE, Zang Y, Sen M, Li C, Wang L, Egner PA, et al.
Prevention of carcinogen‑induced oral cancer by sulforaphane.
Cancer Prev Res (Philadelphia, Pa) 2016;9:547‑57.
Filomeno M, Bosetti C, Garavello W, Levi F, Galeone C,
Negri E, et al. The role of a Mediterranean diet on the risk of
oral and pharyngeal cancer. Br J Cancer 2014;111:981‑6.
Giraldi L, Panic N, Cadoni G, Boccia S, Leoncini E. Association
between Mediterranean diet and head and neck cancer: Results of a
large case‑control study in Italy. Eur J Cancer Prev 2017;26:418‑23.
Fahey JW, Stephenson KK, Wallace AJ. Dietary amelioration
of helicobacter infection. Nutr Res (New York, NY)
;35:461‑73.
Hołubiuk Ł, Imiela J. Diet and Helicobacter pylori infection. Prz
Gastroenterol 2016;11:150‑4.
Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V,
et al. Cyclooxygenase‑2 pathway correlates with VEGF
expression in head and neck cancer. Implications for tumor
angiogenesis and metastasis. Neoplasia (New York, NY)
;3:53‑61.
Chiang SL, Velmurugan BK, Chung CM, Lin SH, Wang ZH,
Hua CH, et al. Preventive effect of celecoxib use against cancer
progression and occurrence of oral squamous cell carcinoma. Sci
Rep 2017;7:6235.
García Rodríguez LA, Soriano‑Gabarró M, Bromley S, Lanas A,
Cea Soriano L. New use of low‑dose aspirin and risk of
colorectal cancer by stage at diagnosis: A nested case‑control
study in UK general practice. BMC Cancer 2017;17:637.
Jayaprakash V, Rigual NR, Moysich KB, Loree TR, Nasca MA,
Menezes RJ, et al. Chemoprevention of head and neck cancer
with aspirin: A case‑control study. Arch otolaryngol Head Neck
Surg 2006;132:1231‑6.
Rafei H, Catherine C, Han J, Kaffenberger TM, Maxwell JH.
Aspirin use and survival in head and neck squamous cell
cancer (HNC) patients. J Clin Oncol 2017;35 (15 Suppl):6042.
Kim SA, Roh JL. Aspirin use and head and neck cancer survival:
An observational study of 11,623 person‑years follow‑up. Int J
Clin Oncol 2018;23:52‑8.
Galvao‑Moreira LV, da Cruz M. Screening and early detection
of oral cancer: Current controversies. Acta Odontol Scand
;75:361‑5.
Irani S, Meschi M, Goodarzi A. Influence of education on
oro‑dental knowledge among school hygiene instructors. J Dent
Res Dent Clin Dent Prospects 2009;3:56‑9.
Irani S. Metastasis to the oral soft tissues: A review of 412 cases.
J Int Soc Prev Community Dent 2016;6:393‑401.
Irani S. Metastasis to the Jawbones: A review of 453 cases. J Int
Soc Prev Community Dent 2017;7:71‑81.
Irani S, Moshref M, Lotfi A. Metastasis of a gastric
adenocarcinoma to the mandible: A case report. Oral Oncol
Extra 2004;40:85‑7.
Irani S, Bidari‑Zerehpoush F, Sabeti S. Prevalence of
pathological entities in neck masses: A study of 1208 consecutive
cases. Avicenna J Dent Res 2016;8:e25614.
Mariño R, Haresaku S, McGrath R, Bailey D, McCullough M,
Musolino R, et al. Oral cancer screening practices of oral health
professionals in Australia. BMC Oral Health 2017;17:151.
Jornet PL, Garcia FJ, Berdugo ML, Perez FP, Lopez AP. Mouth
self‑examination in a population at risk of oral cancer. Aust Dent
J 2015;60:59‑64.
Kaczor‑Urbanowicz KE, Martin Carreras‑Presas C, Aro K, Tu M,
Garcia‑Godoy F, Wong DT. Saliva diagnostics‑Current views
and directions. Exp Biol Med (Maywood, NJ) 2017;242:459‑72.
Ishikawa S, Sugimoto M, Kitabatake K, Sugano A, Nakamura M,
Kaneko M, et al. Identification of salivary metabolomic
biomarkers for oral cancer screening. Sci Rep 2016;6:31520.
Carreras‑Torras C, Gay‑Escoda C. Techniques for early diagnosis
of oral squamous cell carcinoma: Systematic review. Med Oral
Patol Oral Cir Bucal 2015;20:e305‑15.
Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology
of HPV‑associated oropharyngeal cancer. Oral Oncol
;50:380‑6.
Irani S, Bidari‑Zerehpoush F. BRCA1/2 mutations in salivary
pleomorphic adenoma and carcinoma‑ex‑pleomorphic adenoma.
J Int Soc Prev Community Dent 2017;7(Suppl 3):S155‑62.
Pierce Campbell CM, Giuliano AR, Torres BN, O’Keefe MT,
Ingles DJ, Anderson RL, et al. Salivary secretory leukocyte
protease inhibitor (SLPI) and head and neck cancer: The cancer
prevention study II nutrition cohort. Oral Oncol 2016;55:1‑5.
Ioachim E, Assimakopoulos D, Goussia AC, Peschos D,
Skevas A, Agnantis NJ. Glycoprotein CD44 expression in benign,
premalignant and malignant epithelial lesions of the larynx: An
immunohistochemical study including correlation with Rb, p53,
Ki‑67 and PCNA. Histol Histopathol 1999;14:1113‑8.
Tongtawee T, Wattanawongdon W, Simawaranon T,
Kaewpitoon S, Kaengpenkae S, Jintabanditwong N, et al.
Expression of cancer stem cell marker CD44 and its
polymorphisms in patients with chronic gastritis, precancerous
gastric lesion, and gastric cancer: A cross‑sectional multicenter
study in Thailand. Biomed Res Int 2017;2017:4384823.
Pereira LHM, Reis IM, Reategui EP, Gordon C, Saint‑Victor S,
Duncan R, et al. Risk stratification system for oral cancer
screening. Cancer Prev Res (Philadelphia, Pa) 2016;9:445‑55.
Zhong LP, Chen GF, Xu ZF, Zhang X, Ping FY, Zhao SF.
Detection of telomerase activity in saliva from oral squamous cell
carcinoma patients. Int J Oral Maxillofac Surg 2005;34:566‑70.
Perisanidis C. Prevalence of EGFR tyrosine kinase domain
mutations in head and neck squamous cell carcinoma:
Cohort study and systematic review. In Vivo (Athens, Greece)
;31:23‑34.
Pal MK, Jaiswar SP, Dwivedi VN, Tripathi AK, Dwivedi A,
Sankhwar P. MicroRNA: A new and promising potential
biomarker for diagnosis and prognosis of ovarian cancer. Cancer
Biol Med 2015;12:328‑41.
Polverini PJ, D’Silva NJ, Lei YL. Precision therapy of head and
neck squamous cell carcinoma. J Dental Res 2018;97:614‑21.
Huang SH, O’Sullivan B. Oral cancer: Current role of
radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal
;18:e233‑40.